4basebio Share Discussion Threads

[multibagger] 17/2/2021 19:55

Welcome aboard !

It was one of those instinctive/intuitive buys for me before doing any research !

The PI World investor presentation in the header fronted by the Chief Executive articulates the business and prospects very well but essentially is made up of

1. The synthetic DNA business
2. The non viral "Hermes" nanoparticle delivery business

Technology validation, scaling and commercialisation through partnerships in the meantime. About £14 million in cash now and debt facilities in the region of £25m available. So expect to burn through cash at a fast clip !

Takeover potential in due course is what is this is all about and I expect that this may take 3-4 years, but may be I am being optimistic - in fact the CE basically says that don't look at revenues and expect it to be loss making.

But given the low liquidity of 4BB and the applicability of Synthetic DNA (hpDNA) in vaccine manufacture on a faster, cheaper and on a much larger scale than the plasmid route, ticks the boxes for my investment in this "picks and shovels" cutting edge biotech play.

Some may see this as another bite at the gene therapy space, if they feel they have missed the MXCT bus.

Whatever your reasons for investing or trading - Good luck and welcome aboard :)

[multibagger] 17/2/2021 19:47

Listed on AIM: 17 Feb 2021



HQ : Cambridge, UK and presence in Madrid, Spain
24 staff, 18 scientists

Total Number of shares: 12,317,473

Free Float 34%

Major Director Holdings:

CE and CSO: Dr. Heikki Lanckreit; Ph.D (Biochemical Engg) : 10.04%
CFO David Roth : 2.5%
Joseph Fernandez: 3.64%

Listed at 118p

Investor Presentation: Jan 2021

[74tom] 17/2/2021 09:47

1. They do not have 100m in cash, it clearly states in the IPO RNS they have £14m...

2. It was valued at cash at the IPO price of 118p, is it good value at £3 & EV of around £20m? I would say yes given the history of the founder.

3. Is it right that an IPO can be priced at 118p but PI's can only buy 100 shares at 180p on the open? Absolutely not.

[the stigologist] 17/2/2021 09:47

LOL good to see you've done such in depth research

[chicken charlie] 17/2/2021 09:17

STIG They have 100 million in cash

[the stigologist] 17/2/2021 09:04

Hugely overblown valuation in my opinion

Gene Therapy may be a hot sector but they are only a potential 'picks and shovel' supplier very much unproven at this stage

IF you want a 'vector' for drug delivery and some actual IP ownership I'd imagine RENE and its exosome potential is much more interesting and the stock is probably more liquid

[tomps2] 17/2/2021 08:46

4basebio #4BB CEO presentation. Good overview of the business and their vision.

hxxps://www.piworld.co.uk/2021/02/15/4basebio-4bb-investor-presentation-february-2021/

[someuwin] 17/2/2021 08:36

12.3m shares. £24m valuation at 200p share price

Cash of £14.4 million cash. So co valued at just £10m.

Super hot sector.

[miti 1000] 17/2/2021 08:16

What was the IPO price ?

[boros10] 17/2/2021 08:11

No stock around. Those who got stock via the spin off out of 4basebio AG (now 2Invest AG) haven't seen the shares appear on their broker's platforms.

[the stigologist] 17/2/2021 08:01

Manufacturing of DNA for Gene Therapies and DNA vaccines